Figure 4 — High mutation load, immune-activated microenvironment, favorable outcome, and better immunotherapeutic efficacy in melanoma patients harboring MUC16/CA125 mutations

Research Paper|Volume 12, Issue 11|pp. 10827–10843

High mutation load, immune-activated microenvironment, favorable outcome, and better immunotherapeutic efficacy in melanoma patients harboring MUC16/CA125 mutations

Back to articleFigure 4(4 of 5)

100%

Figure 4.Correlation of MUC16 mutations with overall survival in 2 cohorts. (A, B) Kaplan-Meier survival analysis based on MUC16 mutational status (left: TCGA; right: ICGC). (C, D) Forest plot representation of association of MUC16 mutations with prognosis (left: TCGA; right: ICGC).